We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
-10.91%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$3.8B
AUM Growth
-$501M
Cap. Flow
-$427M
Cap. Flow %
-11.23%
Top 10 Hldgs %
9.48%
Holding
2,955
New
715
Increased
515
Reduced
468
Closed
751

Sector Composition

Rank Sector Weight
1 Financials 16.01%
2 Healthcare 9.13%
3 Technology 8.13%
4 Consumer Discretionary 6.63%
5 Industrials 4.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BENER
2026
DELISTED
Benessere Capital Acquisition Corp. Right
BENER
$56K ﹤0.01%
395,900
HTCR icon
2027
HeartCore Enterprises
HTCR
$3.86M
$55K ﹤0.01%
1,150
+250
+28% +$9.36K
MCAER
2028
DELISTED
Mountain Crest Acquisition Corp. III Right
MCAER
$55K ﹤0.01%
256,245
MSPRZ
2029
DELISTED
MSP Recovery Inc Warrant
MSPRZ
$54K ﹤0.01%
+25,348
New +$24.8K
PAFOR
2030
DELISTED
Pacifico Acquisition Corp. Rights
PAFOR
$54K ﹤0.01%
417,188
WINVR
2031
DELISTED
WinVest Acquisition Corp. Right
WINVR
$53K ﹤0.01%
590,000
ASCBR
2032
DELISTED
A SPAC II Acquisition Corp. Right
ASCBR
$52K ﹤0.01%
+450,000
New +$46.5K
GLLIR
2033
DELISTED
Globalink Investment Inc. Rights
GLLIR
$51K ﹤0.01%
540,000
SYBX
2034
DELISTED
Synlogic
SYBX
$50K ﹤0.01%
2,898
-216
-7% -$4.67K
BRACR
2035
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
$49K ﹤0.01%
650,000
+435,500
+203% +$63.3K
AREBW
2036
DELISTED
American Rebel Holdings Warrants
AREBW
$48K ﹤0.01%
602
OKUR
2037
OnKure Therapeutics
OKUR
$170M
$47K ﹤0.01%
1,765
RFACR
2038
DELISTED
RF Acquisition Corp. Rights
RFACR
$46K ﹤0.01%
+400,000
New +$47.3K
BBAI.WS icon
2039
BigBear.ai Holdings Warrant
BBAI.WS
$43.4M
$45K ﹤0.01%
+12,336
New +$9.75K
ASLN
2040
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$45K ﹤0.01%
2,287
LCTX icon
2041
Lineage Cell Therapeutics
LCTX
$284M
$44K ﹤0.01%
+27,777
New +$36.6K
CULP icon
2042
Culp Inc
CULP
$44.4M
$43K ﹤0.01%
+10,000
New +$61.4K
CBAY
2043
DELISTED
Cymabay Therapeutics
CBAY
$43K ﹤0.01%
+14,479
New +$34.6K
GGGVR
2044
DELISTED
G3 VRM Acquisition Corp. Rights
GGGVR
$43K ﹤0.01%
475,000
CRMD icon
2045
CorMedix
CRMD
$588M
$42K ﹤0.01%
+10,360
New +$38.5K
TCRT icon
2046
Alaunos Therapeutics
TCRT
$4.62M
$42K ﹤0.01%
227
-140
-38% -$13.4K
VLN.WS
2047
DELISTED
Valens Semiconductor Ltd Warrants
VLN.WS
$42K ﹤0.01%
12,205
MBII
2048
DELISTED
Marrone Bio Innovations, Inc.
MBII
$42K ﹤0.01%
+36,057
New +$37.7K
DTIL icon
2049
Precision BioSciences
DTIL
$194M
$41K ﹤0.01%
856
+483
+129% +$28.4K
HSDT icon
2050
Solana Company
HSDT
$96.9M
$40K ﹤0.01%
1

Similar funds

Boothbay Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, Boothbay Fund Management held 2,955 positions worth $3.8B, down 12% from $4.3B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Boothbay Fund Management withdrew a net $427M in Q2 2022, closing 751 positions and reducing 468 holdings. Its most notable exit was iShares MBS ETF, an estimated $33.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in Restaurant Brands International worth $11.5M.

  • Boothbay Fund Management's largest Q2 2022 buy was Restaurant Brands International: 228,887 shares worth $11.5M.
  • Boothbay Fund Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $49.1M increase.
  • Boothbay Fund Management's biggest Q2 2022 reduction was Sprott Physical Gold and Silver Trust, cutting an estimated $14.2M.
  • Boothbay Fund Management fully exited iShares MBS ETF in Q2 2022, selling an estimated $33.5M.
  • Boothbay Fund Management's ten largest holdings make up 9.5% of its $3.8B portfolio in Q2 2022.
  • Boothbay Fund Management opened 715 new positions and closed 751 in Q2 2022.
  • Boothbay Fund Management's portfolio value fell 12% quarter-over-quarter to $3.8B.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.